Study of Actemura Remission induction of RA and Sequential Maintenance of Remission by Reasonable cost Treatment

Trial Profile

Study of Actemura Remission induction of RA and Sequential Maintenance of Remission by Reasonable cost Treatment

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 29 Dec 2016

At a glance

  • Drugs Tocilizumab (Primary) ; Bucillamine; Tacrolimus
  • Indications Rheumatoid arthritis
  • Focus Therapeutic Use
  • Acronyms STARR-SMARRT
  • Most Recent Events

    • 27 Dec 2016 Status changed from recruiting to discontinued.
    • 28 Jan 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top